Search Back New search Go to resultsDiseaseMain groupHematological Diseases, Non-MalignantProtocol groupAnemias, CytopeniasHemolytic DiseasesDiseaseAnemia, Autoimmune Hemolytic AnemiaSubgroupCold Agglutinin Diseasewarm typeICD10D59.1MeSHAnemia, Hemolytic, AutoimmuneSequenceCADENZA : SUTI6.5, Autoimmune Hemolytic Anemia, Cold Agglutinin Disease, C1 (PID2248) -|- SUTI6.5, C2+ (PID2249)ChemotherapyChemo-substanceBendamustineCiclosporin AFludarabineMycophenolate mofetilPrednisoloneRituximabChemo-substanceBendamustineCiclosporin AFludarabineMycophenolate mofetilPrednisoloneRituximabChemo-substanceBendamustineCiclosporin AFludarabineMycophenolate mofetilPrednisoloneRituximabChemo-substanceBendamustineCiclosporin AFludarabineMycophenolate mofetilPrednisoloneRituximabNo. Substances12 RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionCalcium carbonateColecalciferolCotrimoxazoleDexamethasoneDimetindenEnoxaparinFolic acidGranisetronPantoprazoleParacetamolPegfilgrastimPrednisoloneSutimlimabSupportive substanceBalanced Crystalloid SolutionCalcium carbonateColecalciferolCotrimoxazoleDexamethasoneDimetindenEnoxaparinFolic acidGranisetronPantoprazoleParacetamolPegfilgrastimPrednisoloneSutimlimabSupportive substanceBalanced Crystalloid SolutionCalcium carbonateColecalciferolCotrimoxazoleDexamethasoneDimetindenEnoxaparinFolic acidGranisetronPantoprazoleParacetamolPegfilgrastimPrednisoloneSutimlimabSupportive substanceBalanced Crystalloid SolutionCalcium carbonateColecalciferolCotrimoxazoleDexamethasoneDimetindenEnoxaparinFolic acidGranisetronPantoprazoleParacetamolPegfilgrastimPrednisoloneSutimlimabNo. Substances125610Protocol classificationTherapy classificationalternativecurrent standardIntensityStandard doseTherapy indicationFirst lineRefractory diseaseSecond lineseveral possibleThird line Therapy phaseTherapy intentiondisease controlRisksArthalgiaCardiotoxicityDyspneaEmetogenicity (MASCC/ESMO)Febrile NeutropeniaHeadacheHerpes ZosterHyperglycemiaHypertensionHypotensionInfectionsMyalgiasNasopharyngitisNeutropeniaParesthesiaPneumoniaPyrexiaRashRenal failure! only studiesPublicationAuthorBerentsen SBirgens HEmilia GHoward JMichel MRöth ADiseaseautoimmunhämolytische Anämie, kälteagglutinin-induzierte Durchblutungsstörungenautoimmunhämolytische Anämie, Kälteagglutininerkrankungautoimmunhämolytische Anämie, KälteagglutininkrankheitAutoimmunhämolytische Anämie, Kälteagglutininkrankheit, symptomatisch, Hämoglobinwert unter 10.0 g/dL, autoimmunhämolytische Anämie, vom Wärmetyp, Drittlinieautoimmunhämolytische Anämie, vom Wärmetyp, refraktäre Erkrankungprimäre autoimmunhämolytische Anämie, vom Wärmetypprimäre autoimmunhämolytische Anämie, vom Wärmetyp, ErstlinieOriginDepartment of Haematology, Copenhagen University Hospital, HerlevDepartment of Medicine, Haugesund Hospital, Haugesund, NorwayDepartment of Research and Innovation, Haugesund Hospital, Hausgesund, NorwayDipartimento di Scienze Mediche, Oncologiche e Radiologiche, Università di Modena, ItalyHaugesund Hospital, Haugesund, NorwayRoyal Free Hospital and University College Medical School, UKUniversite Paris-Est Creteil, France, the RAIHA studyWest German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, German, CADENZA trialProtocols in Revision 10 protocols foundProtocols under revision.Mycophenolate Mofetil (500/1000), Autoimmune Hemolytic Anemia, warm type (PID2014 V1.0)Prednisolone (1.5/0.75/0.5) / Rituximab 375, Autoimmune Hemolytic Anemia, warm type (PID2007 V1.0)Prednisolone (1.5/0.75/0.5), Autoimmune Hemolytic Anemia, warm type (PID2006 V1.0)Prednisolone 1 / Rituximab 1000, Autoimmune Hemolytic Anemia, warm type (PID2015 V1.0)Prednisolone 5 / Ciclosporin (2.5/1.5), Autoimmune Hemolytic Anemia, warm type (PID2013 V1.0)Rituximab 375 / Bendamustine 90, Autoimmune Hemolytic Anemia / Cold Agglutinin Disease (PID1089 V1.2)Rituximab 375 / Fludarabine 25, Autoimmune Hemolytic Anemia, Cold Agglutinin Disease (PID2022 V1.0)Rituximab 375, Autoimmune Hemolytic Anemia, Cold Agglutinin Disease (PID2005 V1.0)Sutimlimab 6.5, Autoimmune Hemolytic Anemia, Cold Agglutinin Disease, Cycle 1. (PID2248 V1.0)Sutimlimab 6.5, Autoimmune Hemolytic Anemia, Cold Agglutinin Disease, Cycle 2+. (PID2249 V1.0)
